Skip to content
The Great Grantsby G

This round closed on 22 September 2026. The details below are from that round.

Browse open KWF calls.

KWF

Lead4Life PPP 2026 – Enabling Technologies for Clinical Introduction of Lead-212

€0.5M–€2M per project (total pillar budget €2.0M)||Up to 4 years

12:00 noon; full proposal phase. Matchmaking phase precedes full proposal. Institutes not yet registered must submit registration request at least 6 weeks before closing date.

Last seen in a scan/import: .

Catalog updated: .

These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.

Closed for now. See which open grants match your research. 30s, no email. See my matches →

The KWF Lead4Life PPP 2026 call funds enabling technologies for safe clinical introduction of Pb-212 radiopharmaceuticals, with budgets up to €2 million over four years per project. The call requires a mandatory public-private partnership consortium and targets research on chelators, radiobiology, dosimetry, quality control, and hospital infrastructure for Lead-212 therapies. One-off opportunity open to Dutch institutions; 1-6 projects will be funded.

Details

Funder KWF
Budget €0.5M–€2M per project (total pillar budget €2.0M)
Duration Up to 4 years
Consortium Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory
Application 2-stage: matchmaking phase → full proposal (submit via KWF GMS by 22 Sep 2026)
Frequency One-off
Eligible countries NL

Recently updated

catalog cleanup 2026-07-04: duplicate row (canonical sibling kept)

Eligibility & scope

Health~Holland PPP call for 1–6 projects on enabling technologies for safe clinical use of Pb-212 radiopharmaceuticals (chelators, radiobiology, dosimetry, QC, hospital infrastructure). Requires a public-private consortium with signed Consortium Agreement and Health~Holland PPP compliance. Private party must not be an undertaking in difficulty (RVO declaration required). Clinical/patient-sample context likely.

Who Should Apply

  • •Academic or hospital-based research groups with radiochemistry, radiobiology, or dosimetry expertise
  • •Dutch institutions eligible to coordinate or participate in a public-private consortium
  • •Private-sector partners (pharma, device manufacturers) not in financial difficulty
  • •Research focused on clinical translation: chelator development, quality control, hospital infrastructure for Pb-212
  • •Consortia with a signed Consortium Agreement in place before full proposal submission

Key Dates

  • •Full proposal deadline: 22 September 2026, 12:00 noon (submit via KWF GMS)
  • •Matchmaking phase precedes full proposal; institutes not yet registered must request registration at least 6 weeks before deadline (by 11 August 2026)
  • •Up to four-year project duration

Tips for Applicants

  • ✓The Consortium Agreement must be signed and submitted with the full proposal; do not delay legal agreements until after notification.
  • ✓Private partners must obtain an RVO declaration confirming they are not an undertaking in difficulty; budget time for this bureaucratic step.
  • ✓Lead with clinical feasibility and hospital readiness; KWF prioritises projects with clear pathway to patient access, not bench-only enabling research.

Frequently Asked Questions

What is the budget for the KWF Lead4Life PPP 2026?

Up to €2 million per project over four years; the total pillar budget is €2.0 million, so 1-6 projects will be funded depending on scope.

Who can apply for the Lead4Life PPP?

Dutch academic and hospital-based research groups in a public-private consortium with a signed Consortium Agreement; private partners must not be in financial difficulty.

What technologies does the Lead4Life PPP fund?

Enabling technologies for safe clinical use of Pb-212 radiopharmaceuticals, including chelators, radiobiology, dosimetry, quality control, and hospital infrastructure.

Is the Consortium Agreement required before submitting the full proposal?

Yes, the signed Consortium Agreement is mandatory and must be submitted with the full proposal.

When is the full proposal deadline for Lead4Life PPP 2026?

22 September 2026 at 12:00 noon via KWF GMS; a matchmaking phase precedes the full proposal stage.

kwflead-212radiopharmaceuticalspublic-private-partnershipconsortium-requiredclinical-translationnetherlandstranslational-research

Related on Grantsby

View full call → KWF writing tips
Share ✉ Email X LinkedIn WhatsApp

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Grants for Dutch researchers All KWF open calls

This call has closed. See what's open now.

Get matched against every open call from KWF and the rest of the 65 funders we track, rechecked every week. 30 seconds, no signup needed to preview.

See my matches free →